Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine
Authors
- S. Cedrés (ORCID: https://orcid.org/0000-0002-5068-3124)
- Anna K. Nowak (ORCID: https://orcid.org/0000-0002-9317-9526)
- Weronika Maria Szejniuk (ORCID: https://orcid.org/0000-0001-6790-6710)
- Roslyn J. Francis (ORCID: https://orcid.org/0000-0002-6256-1351)
- Åsa Kristina Öjlert (ORCID: https://orcid.org/0000-0002-2888-8406)
- Lars Tore Gyland Mikalsen (ORCID: https://orcid.org/0000-0001-9836-8468)
- Solfrid Thunold (ORCID: https://orcid.org/0009-0004-9277-7796)
- S.J. Farooqi
- Åslaug Helland (ORCID: https://orcid.org/0000-0002-5520-0275)
- Carin Meltzer (ORCID: https://orcid.org/0000-0003-0752-028X)
- Vilde Drageset Haakensen (ORCID: https://orcid.org/0000-0003-0864-3628)
- Jens Benn Sørensen (ORCID: https://orcid.org/0000-0001-7780-0178)
- M. Simó Perdigó
- Eirik Malinen (ORCID: https://orcid.org/0000-0002-1308-9871)
- Søren Steen Nielsen
- Eivor Hernes
Institutions
- University of Copenhagen (DK)
- Oslo University Hospital (NO)
- The University of Western Australia (AU)
- OsloMet – Oslo Metropolitan University (NO)
- University of Oslo (NO)
- Aalborg University Hospital (DK)
- Sir Charles Gairdner Hospital (AU)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Vall d'Hebron Hospital Universitari (ES)
- Vall d'Hebron Institute of Oncology (ES)
- Aalborg University (DK)
Publication Details
- Journal
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1007/s00259-024-06853-0
- Citations
- 3
- Primary Topic
- Occupational and environmental lung diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- Bristol-Myers Squibb
- Universitetet i Oslo
- Helse Sør-Øst RHF